SAVIMS

SAVIMS logo white
Menu

Resource Type

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Confidential Pfizer Document Reveals Alarming Adverse Events Data

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Horowitz, D. (2023, June 14). Confidential Pfizer document shows the company observed 1.6 million adverse events covering nearly every organ system. Conservative Review. https://www.conservativereview.com/horowitz-confidential-pfizer-document-shows-the-company-observed-1-6-million-adverse-events-covering-n Summary: A recent article by Daniel Horowitz discusses a confidential Pfizer document that reveals the company observed approximately 1.6 million adverse events associated with its vaccine. The document, dated August […]

COVID-19, Covid-19 vaccines, Genetic vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

The Complexities of mRNA Vaccines: A Gene Therapy Perspective

| | COVID-19, Covid-19 vaccines, Genetic vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Banoun, H. (2023). mRNA: gene therapy or vaccine? SAVIMS (South Africa Vaccine Injury Medicolegal Study Group). Summary: Hélène Banoun’s article delves into the intricate nature of mRNA vaccines, positioning them within the broader context of gene therapy. She explains the dual role of RNA viruses, particularly coronaviruses, in infecting host cells and highlights the

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Insights into mRNA Vaccine Concerns from Dalgleish and Malhotra

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Dalgleish, A. (2023, April 1). Narrative crumbles as doctors thank Aseem Malhotra and Angus Dalgleish for explaining how the mRNA vaccines are injuring their patients. Daily Sceptic. https://dailysceptic.org/2023/04/01/narrative-crumbles-as-doctors-thank-aseem-malhotra-and-angus-dalgleish-for-explaining-how-the-mrna-vaccines-are-injuring-their-patients/ Summary: In his article, Dr Angus Dalgleish expresses deep concern regarding the ongoing rollout of COVID-19 booster vaccines in the UK, arguing that they lack scientific

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive Overview of Early COVID-19 Treatment Protocols

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: FLCCC Alliance. (2023). I-CARE early COVID treatment summary. Retrieved from https://www.flccc.net Summary: The FLCCC Alliance outlines a structured protocol for the early treatment of COVID-19, emphasising the importance of immediate intervention after the onset of symptoms. First-line treatments include Ivermectin (0.4-0.6 mg/kg), Hydroxychloroquine (200 mg twice daily), and antiseptic mouthwash for symptom management. Ivermectin

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

I-CARE Early COVID Treatment Protocol Overview

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: FLCCC Alliance. (2023). I-CARE: Early COVID treatment protocol. Retrieved from [insert link] Summary: The I-CARE protocol, developed by the FLCCC Alliance, aims to provide healthcare professionals with a structured approach to early COVID-19 treatment, focusing on preventing hospitalisation and mortality. The protocol recommends a combination of first-line treatments such as ivermectin, hydroxychloroquine, and various

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Alarming COVID-19 Death Statistics: The Vaccinated Majority

| | COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: By The Exposé. (2023, March 26). UK Government quietly confirms Triple+ vaccinated accounted for 92% of COVID deaths in 2022. The Exposé. https://expose-news.com/2023/03/26/uk-gov-confirms-vaccinated-accounted-for-92-percent-of-covid-deaths-in-2022 Summary: An article by The Exposé highlights concerning statistics from the UK Government, revealing that the triple-vaccinated population accounted for 92% of COVID-19 deaths in 2022, raising questions about vaccine efficacy.

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Government Data Reveals Alarming COVID-19 Vaccine Death Rates

| | COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: The Exposé. (2023, March 21). Government publishes shocking figures on COVID vaccine deaths: 1 in every 73 vaccinated people died by June 2022 compared to just 1 in every 172 not-vaccinated people. expose-news.com/2023/03/21/1-in-73-covid-vaccinated-died-by-june-22 Summary: According to data from the UK Office for National Statistics (ONS), by June 2022, 1 in every 73 vaccinated individuals

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Confronting the COVID Vaccine Debate: A Call for Transparency

| | COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Kirsch, S. (2023, March 1). Why is everyone so afraid to talk about the elephant in the room? Steve Kirsch. Substack. https://stevekirsch.substack.com/p/why-is-everyone-so-afraid-to-talk Summary: In his article, Steve Kirsch presents a critical view of the COVID-19 response, arguing that significant errors were made regarding vaccines, masks, social distancing, and lockdowns. He contends that vaccines have

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Cardiovascular Complications from COVID-19 mRNA Vaccines

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Yasmin, F., Najeeb, H., Naeem, U., Moeed, A., Atif, A. R., Asghar, M. S., Nimri, N., Saleem, M., Bandyopadhyay, D., Krittanawong, C., Eljack, M. M. F., Tahir, M. J., & Waqar, F. (2023). Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immunity, Inflammation and Disease, 11, e807.

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Effectiveness of the COVID-19 Bivalent Vaccine

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Shrestha, N. K., Burke, P. C., Nowacki, A. S., Simon, J. F., Hagen, A., & Gordon, S. M. (2022). Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine. medRxiv. https://doi.org/10.1101/2022.12.17.22283625 Summary: This study evaluated the effectiveness of the bivalent COVID-19 vaccine among 51,011 employees at the Cleveland Clinic. The results indicated a 30% effectiveness

Scroll to Top